Press release
Cholangiocarcinoma Treatment Market Size in the 7MM is expected to grow a significant CAGR by 2034, estimates DelveInsight | Incyte, Agios Pharmaceuticals, Servier Pharmaceuticals, Taiho Pharma, Astrazeneca, Decalth Systems, Basilea Pharmaceuticals, Taiho
Cholangiocarcinoma Market
To know in detail about the Cholangiocarcinoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cholangiocarcinoma Market Forecast- https://www.delveinsight.com/sample-request/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Some of the key facts of the Cholangiocarcinoma Market Report:
• The Cholangiocarcinoma market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In December 2024, Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company revolutionizing drug discovery through advanced computational and experimental technologies, and Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. focused on improving treatment outcomes for patients with limited therapeutic options, announced today an exclusive global licensing agreement for lirafugratinib (RLY-4008). Lirafugratinib is a selective oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), being developed for patients with FGFR2-driven cholangiocarcinoma (CCA) and other FGFR2-altered solid tumors. The partnership follows Relay's recent positive FDA interaction and previously reported promising data in cholangiocarcinoma and other solid tumors.
• In 2023, the total number of cholangiocarcinoma incident cases across the 7MM was approximately 45,000, with around 45% of these cases being intrahepatic.
• According to DelveInsight's estimates, there were approximately 14,000 new cases of cholangiocarcinoma in the United States in 2023.
• In the United States, approximately 6,000 cases of cholangiocarcinoma were classified as intrahepatic cancer.
• Cholangiocarcinoma is primarily observed in individuals within the 70-79 year age group.
• Several treatments are currently approved for cholangiocarcinoma, including PEMAZYRE (pemigatinib), TIBSOVO (ivosidenib), and LYTGOBI (futibatinib). Among therapies targeting various FGFR mutations, PEMAZYRE is anticipated to capture the largest market share.
• Key Cholangiocarcinoma Companies: Incyte, Agios Pharmaceuticals, Servier Pharmaceuticals, Taiho Pharma, Astrazeneca, Decalth Systems, Basilea Pharmaceuticals, Taiho Oncology, Eisai Pharmaceuticals, TransThera Sciences (Nanjing), Inc., and others
• Key Cholangiocarcinoma Therapies: PEMAZYRE (pemigatinib), TIBSOVO (ivosidenib), LYTGOBI (futibatinib), Imfinzi (durvalumab), Melphalan, Derazantinib, Futibatinib (TAS-120), E7090, TT-0040, and others
Get a Free sample for the Cholangiocarcinoma Market Report @ https://www.delveinsight.com/sample-request/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Cholangiocarcinoma Epidemiology Segmentation:
The Cholangiocarcinoma market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Cholangiocarcinoma
• Prevalent Cases of Cholangiocarcinoma by severity
• Gender-specific Prevalence of Cholangiocarcinoma
• Diagnosed Cases of Episodic and Chronic Cholangiocarcinoma
Download the report to understand which factors are driving Cholangiocarcinoma epidemiology trends @ Cholangiocarcinoma Epidemiological Insights- https://www.delveinsight.com/sample-request/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Cholangiocarcinoma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cholangiocarcinoma market or expected to get launched during the study period. The analysis covers Cholangiocarcinoma market uptake by drugs, patient uptake by therapies, and sales of each drug.
Cholangiocarcinoma Therapies and Key Companies
• PEMAZYRE (pemigatinib): Incyte
• TIBSOVO (ivosidenib): Agios Pharmaceuticals/Servier Pharmaceutical
• LYTGOBI (futibatinib): Taiho Pharma
• Imfinzi (durvalumab): Astrazeneca
• Melphalan: Decalth Systems
• Derazantinib: Basilea Pharmaceuticals
• Futibatinib (TAS-120): Taiho Oncology
• E7090: Eisai Pharmaceuticals
• TT-0040: TransThera Sciences (Nanjing), Inc.
Cholangiocarcinoma Market Drivers
• Rising Incidence
• Technological advancements in the identification of biomarkers
• Increasing R&D Activities
Cholangiocarcinoma Market Barriers
• Lack of awareness about the disease
• Heterogeneity of the disease
• Delayed Diagnosis
Scope of the Cholangiocarcinoma Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Key Cholangiocarcinoma Companies: Incyte, Agios Pharmaceuticals, Servier Pharmaceuticals, Taiho Pharma, Astrazeneca, Decalth Systems, Basilea Pharmaceuticals, Taiho Oncology, Eisai Pharmaceuticals, TransThera Sciences (Nanjing), Inc., and others
• Key Cholangiocarcinoma Therapies: PEMAZYRE (pemigatinib), TIBSOVO (ivosidenib), LYTGOBI (futibatinib), Imfinzi (durvalumab), Melphalan, Derazantinib, Futibatinib (TAS-120), E7090, TT-0040, and others
• Cholangiocarcinoma Therapeutic Assessment: Cholangiocarcinoma current marketed and Cholangiocarcinoma emerging therapies
• Cholangiocarcinoma Market Dynamics: Cholangiocarcinoma market drivers and Cholangiocarcinoma market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Cholangiocarcinoma Unmet Needs, KOL's views, Analyst's views, Cholangiocarcinoma Market Access and Reimbursement
Discover more about therapies set to grab major Cholangiocarcinoma market share @ Cholangiocarcinoma Treatment Landscape- https://www.delveinsight.com/sample-request/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Cholangiocarcinoma Market Report Introduction
2. Executive Summary for Cholangiocarcinoma
3. SWOT analysis of Cholangiocarcinoma
4. Cholangiocarcinoma Patient Share (%) Overview at a Glance
5. Cholangiocarcinoma Market Overview at a Glance
6. Cholangiocarcinoma Disease Background and Overview
7. Cholangiocarcinoma Epidemiology and Patient Population
8. Country-Specific Patient Population of Cholangiocarcinoma
9. Cholangiocarcinoma Current Treatment and Medical Practices
10. Cholangiocarcinoma Unmet Needs
11. Cholangiocarcinoma Emerging Therapies
12. Cholangiocarcinoma Market Outlook
13. Country-Wise Cholangiocarcinoma Market Analysis (2020-2034)
14. Cholangiocarcinoma Market Access and Reimbursement of Therapies
15. Cholangiocarcinoma Market Drivers
16. Cholangiocarcinoma Market Barriers
17. Cholangiocarcinoma Appendix
18. Cholangiocarcinoma Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
List of the Top Selling Market Research Reports in 2025
intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
vulvar cancer market- https://www.delveinsight.com/report-store/vulvar-cancer-pipeline-insight
healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
phototherapies for psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
sepsis market- https://www.delveinsight.com/report-store/sepsis-market-insight
lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
cart pipeline- https://www.delveinsight.com/report-store/cart-cell-therapy-competitive-landscape
dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
total knee arthroplasty market- https://www.delveinsight.com/report-store/knee-reconstruction-devices-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cholangiocarcinoma Treatment Market Size in the 7MM is expected to grow a significant CAGR by 2034, estimates DelveInsight | Incyte, Agios Pharmaceuticals, Servier Pharmaceuticals, Taiho Pharma, Astrazeneca, Decalth Systems, Basilea Pharmaceuticals, Taiho here
News-ID: 3878781 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Cholangiocarcinoma
Cholangiocarcinoma Market to Reach USD 2.87 Billion by 2034
The global cholangiocarcinoma market is positioned for steady growth, driven by increasing awareness, improved diagnostic capabilities, and the expanding approval of targeted drugs. Between 2024 and 2034, a combination of innovative drug pipelines, biomarker-based diagnostics, and supportive policy frameworks is expected to transform patient outcomes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70843
Market Overview
• Market Size (2024): USD 1.32 billion
• Forecasted Market Size (2034): USD 2.87 billion
• CAGR (2024-2034): ~8.1%
• Key Drivers: Genomic…
Cholangiocarcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Cholangiocarcinoma Pipeline Insight 2024" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cholangiocarcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Cholangiocarcinoma Pipeline Report
• DelveInsight's Cholangiocarcinoma pipeline…
Cholangiocarcinoma Market Size was USD 786.1 million in 2021
The Cholangiocarcinoma Market is expected to show positive growth attributed to the increased diagnosed prevalence and also, the launch of upcoming devices during the forecast period. Moreover, advances in disease mechanisms have yielded new diagnostic and treatment approaches, opening avenues to better treatment interventions.
The Cholangiocarcinoma market report provides current treatment practices, emerging drugs, Cholangiocarcinoma market share of the individual therapies, current and forecasted Cholangiocarcinoma market Size from 2019 to 2032…
Global Cholangiocarcinoma Market
The global cholangiocarcinoma market size was valued at USD 185 million in 2021 and is projected to reach around USD 450 million in 2030 exhibiting a CAGR of 12.5% in the forecasted period. The high expenditure on the healthcare sector by the management and the customers boosts the market growth. Increasing infection like liver fluke will boost the demand for the market, growing the treatment of bile duct cancer impacting…
Cholangiocarcinoma Market Overview by Advance Technology, Future Outlook 2032
The global cholangiocarcinoma market size was valued at USD 185 million in 2021 and is projected to reach around USD 450 million in 2030 exhibiting a CAGR of 12.5% in the forecasted period. The high expenditure on the healthcare sector by the management and the customers boosts the market growth. Increasing infection like liver fluke will boost the demand for the market, growing the treatment of bile duct cancer impacting…
Cholangiocarcinoma Market Size was USD 786.1 Million in 2021
"The increase in Cholangiocarcinoma market size is a direct consequence of increasing incident population of Cholangiocarcinoma, an increase in investment in the R&D of drugs leading to a rich pipeline in the 7MM"
The Cholangiocarcinoma market report provides current treatment practices, emerging drugs, cholangiocarcinoma market share of the individual therapies, current and forecasted cholangiocarcinoma market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current cholangiocarcinoma…
